anmelden
SPI
20.263,22
PKT
-173,75
PKT
-0,85
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 24.02.12 | Schindler neutral | UBS AG | |
| 24.02.12 | Zurich Insurance outperform | Macquarie Research | |
| 24.02.12 | Swiss Re neutral | Nomura | |
| 24.02.12 | Swiss Re underperform | RBC Capital Markets | |
| 24.02.12 | Swiss Life buy | Nomura | |
| 24.02.12 | BB Biotech halten | Independent Research GmbH | |
| 28.02.12 | Allreal neutral | Sarasin Research | |
| 24.02.12 | ABB (Asea Brown Boveri) outperform | Sanford C. Bernstein and Co., Inc. | |
| 23.02.12 | Roche overweight | J.P. Morgan Cazenove | |
| 23.02.12 | Swiss Re buy | Sarasin Research | |
| 23.02.12 | Sulzer buy | Sarasin Research | |
| 22.02.12 | Zurich Insurance neutral | J.P. Morgan Cazenove | |
| 22.02.12 | Straumann neutral | Sarasin Research | |
| 22.02.12 | Zurich Insurance hold | Commerzbank Corp. & Markets | |
| 22.02.12 | Holcim hold | Deutsche Bank AG | |
| 21.02.12 | ABB (Asea Brown Boveri) overweight | J.P. Morgan Cazenove | |
| 21.02.12 | Schindler buy | Sarasin Research | |
| 21.02.12 | Swatch (I) buy | Deutsche Bank AG | |
| 21.02.12 | Givaudan neutral | Credit Suisse Group | |
| 21.02.12 | ABB (Asea Brown Boveri) outperform | Cheuvreux SA | |
| 21.02.12 | Swisscom buy | Nomura | |
| 21.02.12 | Julius Bär buy | Sarasin Research | |
| 21.02.12 | Zurich Insurance outperform | RBC Capital Markets | |
| 21.02.12 | Zurich Insurance halten | Independent Research GmbH | |
| 20.02.12 | Holcim neutral | Citigroup Corp. | |
| 20.02.12 | Clariant buy | Citigroup Corp. | |
| 20.02.12 | Zurich Insurance buy | ING | |
| 20.02.12 | ABB (Asea Brown Boveri) kaufen | Hamburger Sparkasse AG (Haspa) | |
| 20.02.12 | UBS halten | Hamburger Sparkasse AG (Haspa) | |
| 20.02.12 | Nestlé halten | Independent Research GmbH | |
| 20.02.12 | Givaudan neutral | UBS AG | |
| 17.02.12 | EMS-CHEMIE buy | Sarasin Research | |
| 17.02.12 | Zurich Insurance neutral | Merrill Lynch & Co., Inc. | |
| 17.02.12 | BB Biotech kaufen | Hanseatischer Börsendienst | |
| 17.02.12 | Givaudan sell | Citigroup Corp. | |
| 17.02.12 | Swatch (I) buy | Sarasin Research | |
| 17.02.12 | Givaudan overweight | J.P. Morgan Cazenove | |
| 17.02.12 | ABB (Asea Brown Boveri) overweight | J.P. Morgan Cazenove | |
| 17.02.12 | Zurich Insurance buy | Nomura | |
| 17.02.12 | ABB (Asea Brown Boveri) halten | Independent Research GmbH |
